The nation’s biggest pharmacy benefits manager has decided to cover two new drugs that lower artery-clogging cholesterol but raise concern over prices that can top $14,000 a year. Express Scripts said ...
NEW YORK, July 31 (Reuters) - Pharmacy benefit manager Express Scripts Holding Co said on Monday it would favor drugmaker Mylan Inc's versions of the EpiPen lifesaving allergy treatment over the ...
The PBM declined to list what discounts it had negotiated, but said it expected to spend $750 million on this cholesterol-lowering class in 2016. Express Scripts, the nation’s largest pharmacy benefit ...
Express Scripts, one of the largest pharmacy benefit managers in the country, will cover AbbVie’s new hepatitis C treatment and will no longer cover Gilead Sciences treatments, according to a Reuters ...
The nation’s biggest pharmacy benefits manager has decided to cover two new drugs that lower artery-clogging cholesterol but raise concern over prices that can top $14,000 a year. Express Scripts said ...
NEW YORK (Reuters) - Pharmacy benefit manager Express Scripts Holding Co said on Monday it would favor drugmaker Mylan Inc's versions of the EpiPen lifesaving allergy treatment over the allergy ...
The nation's biggest pharmacy benefits manager has decided to cover two new drugs that lower artery-clogging cholesterol but raise concern over prices that can top $14,000 a year. Express Scripts said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results